These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 2144108)

  • 21. Differential susceptibility to activation-induced apoptosis among peripheral Th1 subsets: correlation with Bcl-2 expression and consequences for AIDS pathogenesis.
    Ledru E; Lecoeur H; Garcia S; Debord T; Gougeon ML
    J Immunol; 1998 Apr; 160(7):3194-206. PubMed ID: 9531275
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Classification of CD4+ T helper cell clones in human melanoma.
    Goedegebuure PS; Lee KY; Matory YL; Peoples GE; Yoshino I; Eberlein TJ
    Cell Immunol; 1994 Jun; 156(1):170-9. PubMed ID: 7911074
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hyperimmunoglobulinemia E syndrome associated with coronary artery aneurysms: deficiency of central memory CD4+ T cells and expansion of effector memory CD4+ T cells.
    Young TY; Jerome D; Gupta S
    Ann Allergy Asthma Immunol; 2007 Apr; 98(4):389-92. PubMed ID: 17458437
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Exposure to T helper 2 cytokines in vivo before encounter with antigen selects for T helper subsets via alterations in antigen-presenting cell function.
    Cua DJ; Coffman RL; Stohlman SA
    J Immunol; 1996 Oct; 157(7):2830-6. PubMed ID: 8816386
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Flow cytometric analysis for cytokine production identifies T helper 1, T helper 2, and T helper 0 cells within the human CD4+CD27- lymphocyte subpopulation.
    Elson LH; Nutman TB; Metcalfe DD; Prussin C
    J Immunol; 1995 May; 154(9):4294-301. PubMed ID: 7722288
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Different cytokine production and activation marker profiles in circulating cutaneous-lymphocyte-associated antigen T cells from patients with acute or chronic atopic dermatitis.
    Antúnez C; Torres MJ; Mayorga C; Cornejo-García JA; Santamaría-Babi LF; Blanca M
    Clin Exp Allergy; 2004 Apr; 34(4):559-66. PubMed ID: 15080808
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Functional heterogeneity among human inducer T cell clones.
    Umetsu DT; Jabara HH; DeKruyff RH; Abbas AK; Abrams JS; Geha RS
    J Immunol; 1988 Jun; 140(12):4211-6. PubMed ID: 2967331
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human T helper cell differentiation is regulated by the combined action of cytokines and accessory cell-dependent costimulatory signals.
    Palmer EM; van Seventer GA
    J Immunol; 1997 Mar; 158(6):2654-62. PubMed ID: 9058798
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [A role for T-helper type 1 and type 2 cytokines in the pathogenesis of various human diseases].
    Kasakura S
    Rinsho Byori; 1998 Sep; 46(9):915-21. PubMed ID: 9800477
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cytokines and peritonitis in continuous ambulatory peritoneal dialysis: immunodeviation and immunodeficiency.
    Klínger J; Enríquez J; Arturo JA; Delgado M; Avila G; Ceballos O
    Adv Perit Dial; 2002; 18():170-6. PubMed ID: 12402613
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evolving T cell responses in murine schistosomiasis. Th2 cells mediate secondary granulomatous hypersensitivity and are regulated by CD8+ T cells in vivo.
    Chensue SW; Warmington KS; Hershey SD; Terebuh PD; Othman M; Kunkel SL
    J Immunol; 1993 Aug; 151(3):1391-400. PubMed ID: 8335935
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Kinetics of ex-vivo cytokine production by splenocytes during murine acquired immunodeficiency syndrome (MAIDS).
    Akarid K; Pocidalo MA; Desforges B; Sinet M
    Eur Cytokine Netw; 1995; 6(3):181-5. PubMed ID: 8589275
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transient remission after intercurrent measles infection in a patient with hyperimmunoglobulin E syndrome.
    Lin CY
    Pediatr Res; 1986 Jul; 20(7):685-8. PubMed ID: 3487769
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Selective insufficiency of IFN-gamma secretion in patients with hyper-IgE syndrome.
    Ito R; Mori M; Katakura S; Kobayashi N; Naruto T; Osamura Y; Aihara Y; Yokota S
    Allergy; 2003 Apr; 58(4):329-36. PubMed ID: 12708982
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Case of Sézary syndrome with accentuated hyperimmunoglobulinemia E--evidence for malignant proliferation of IgE-specific helper T lymphocytes].
    Mitsuya H; Sato M; Fujimoto K; Kawano F; Kishimoto S; Hirano T
    Nihon Naika Gakkai Zasshi; 1983 Sep; 72(9):1202-10. PubMed ID: 6229590
    [No Abstract]   [Full Text] [Related]  

  • 36. Clinical syndrome of chemotaxis defect, infections, and hyperimmunoglobulinemia E. A case report.
    Wyre HW; Johnson WT
    Arch Dermatol; 1978 Jan; 114(1):74-7. PubMed ID: 619787
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Defective neutrophil chemotaxis and hyperimmunoglobulinemia E-a reversible defect?
    Fontan G; Lorente F; Garcia Rodriguez MC; Ojeda JA
    Acta Paediatr Scand; 1976 Jul; 65(4):509-11. PubMed ID: 937002
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transfer factor therapy in hyperimmunoglobulinaemia E syndrome.
    Kesarwala HH; Prasad RV; Szep R; Oldman E; Lane S; Papageorgiou PS
    Clin Exp Immunol; 1979 Jun; 36(3):465-72. PubMed ID: 487648
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Recurrent staphylodermas in marked IgE elevation: the hyper-IgE syndrome].
    Huber A; Mietens C
    Klin Padiatr; 1987; 199(6):445-6. PubMed ID: 3431023
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hyper IgE syndrome: review and future directions.
    Freeman AF; Holland SM
    Expert Rev Clin Immunol; 2005 Nov; 1(4):645-51. PubMed ID: 20477605
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.